Orphalan
Pre-clinicalWe believe patients with a rare disease should have access to innovative treatment that improves their care and positively impacts their lives and those of their loved ones.
Founded
2011
Focus
Small Molecules
About
We believe patients with a rare disease should have access to innovative treatment that improves their care and positively impacts their lives and those of their loved ones.
Funding History
2Total raised: $35M
Series B$25MUndisclosedJun 15, 2020
Series A$10MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2011
LocationParis, France
StagePre-clinical
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile